Identification of Undiagnosed Hyperlipidemia: Do Work Site Screening Programs Work?

Area of Science:

• Cardiovascular Health
• Preventive Medicine
• Occupational Health

Background:

• Hyperlipidemia is a major risk factor for cardiovascular disease.
• Workplace health screenings offer a unique opportunity to identify individuals at risk.
• Early detection and management of hyperlipidemia are crucial for public health.

Purpose of the Study:

• To determine the rate of hyperlipidemia detected through workplace screening in previously undiagnosed individuals.
• To assess the association between workplace hyperlipidemia screening and subsequent medical care utilization.
• To evaluate changes in lipid profiles among individuals diagnosed with hyperlipidemia post-screening.

Main Methods:

• A nonexperimental longitudinal study was conducted involving 18,993 employees from 39 self-insured US employers.
• Lipid profiles (total cholesterol, LDL, HDL, triglycerides) were measured during screening.
• Discrete-time survival analysis and paired t tests were used to analyze diagnostic rates and lipid profile changes over one year.

Main Results:

• Hyperlipidemia was identified in 9.9% (1872) of participants during screening.
• A significantly higher rate of new hyperlipidemia diagnoses occurred in the first month post-screening (OR: 2.99).
• Among 987 individuals followed for one year, significant reductions were observed in total cholesterol (-8.5%) and LDL levels (-10.2%).

Conclusions:

• Workplace health screenings are associated with increased physician visits and hyperlipidemia prescriptions.
• Screening positively impacts the management and treatment of hyperlipidemia in an insured workforce.
• One-year follow-up demonstrated significant improvements in lipid profiles for those identified with hyperlipidemia.